Biohaven BHVN Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $551.31M-13.2% | $635.07M-6.7% | $680.59M-2.4% | $697.03M-15.8% | $827.48M+4.0% | ||
| $102.94M-6.7% | $110.31M-1.5% | $111.98M+7.3% | $104.33M+8.7% | $95.95M+7.5% | ||
| $654.25M-12.2% | $745.38M-6.0% | $792.58M-1.1% | $801.36M-13.2% | $923.43M+4.3% | ||
| -$654.25M+12.2% | -$745.38M+6.0% | -$792.58M+1.1% | -$801.36M+13.2% | -$923.43M-4.3% | ||
| —— | —— | $13.6M-61.4% | $35.25M-1.0% | $35.61M-9.7% | ||
| -$646.57M+12.3% | -$737.38M+5.3% | -$778.97M-1.7% | -$766.11M+13.7% | -$887.82M-5.0% | ||
| $1.11M-23.4% | $1.44M+26.6% | $1.14M+32.6% | $859K+10.8% | $775K+5.4% | ||
| -$647.68M+12.3% | -$738.82M+5.3% | -$780.11M-1.7% | -$766.97M+13.7% | -$888.6M-5.0% | ||
| -$5.58+18.8% | -$6.87+8.8% | -$7.53+0.8% | -$7.59+18.3% | -$9.29+0.3% | ||
| -$644.2M+12.4% | -$735.46M+6.0% | -$782.77M+1.3% | -$792.68M+13.3% | -$914.78M-4.3% | ||
| -$654.25M+12.2% | -$745.38M+6.0% | -$792.58M+1.1% | -$801.36M+13.2% | -$923.43M-4.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Biohaven profitable?
- Biohaven is not currently profitable: it reported a net loss of $647.7M over the trailing twelve months.
- What is Biohaven's earnings per share?
- Biohaven's diluted EPS over the trailing twelve months is $-5.58.
- Where does Biohaven's income statement data come from?
- Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.